Replies to post #180688 on Biotech Values

[ciotera]

risk to GILD’s HIV franchise

I think there is minimal risk that TAF will fail clinically.
However, there is significant risk that TAF may fail commercially.

[jq1234]

>> GILD: initial TAF phase-3 data are reported in 4Q14.

TAF top line data will be reported this qtr.

[north40000]

Does this satisfy your expectations?:

http://www.smarteranalyst.com/2014/09/24/gilead-positive-taf-data-suggests-will-life-viread-says-cowen-raises-pt-125/